Proposition clarity and buyer relevance
NHS Commercial Readiness Review
Understand how ready you are to win, grow or scale NHS revenue.
A focused diagnostic for healthtech, digital health and public-sector suppliers who need a clearer view of their commercial strengths, gaps, risks and next priorities.
Why this review
A strong product is not always enough to create NHS revenue.
Many suppliers have credible products, engaged conversations and committed teams, but still lose time because the commercial route is not sufficiently clear. The issue is often not effort. It is unclear positioning, weak buyer focus, uncertain procurement routes, inconsistent pipeline qualification or a lack of commercial discipline around bids, pricing and account growth.
This review gives you an independent, senior commercial view of where you are now and what should be strengthened first.
What it covers
The review looks across the commercial system, not just the sales message.
You complete a structured questionnaire. Nadine reviews the responses personally and turns the findings into a tailored report showing strengths, risks and priority actions.
Target organisations, stakeholders and decision routes
NHS and public-sector procurement readiness
Pipeline quality, CRM discipline and forecast confidence
Bid, framework and evidence readiness
Pricing, commercial terms and route-to-market assumptions
Strategic account growth and customer expansion
Leadership visibility, governance and next-step control
Choose your level
One review, three practical levels of support.
Readiness Report
A focused view of current readiness and priority issues.
- Structured questionnaire
- Written report
- Key commercial risks
- Priority recommendations
Review + Call
Founders or leaders who want interpretation and discussion.
- Everything in the Readiness Report
- 60-minute review call
- Discussion of findings
- Practical next steps
Readiness Sprint
Teams that want a practical plan to act on the findings.
- Report and review call
- Deeper priority review
- 30/60/90-day action plan
- Final price agreed after scoping
Typical routeMost organisations begin with the Review + Call, then decide whether a deeper sprint or fractional support is needed.
Example output
A sample of the kind of insight included in the report.
The example below is based on a fictional digital health supplier, CareFlow Analytics Ltd. It shows the style and level of interpretation included in the NHS Commercial Readiness Review.
CRM stages may not reflect verified buyer progress
CareFlow Analytics has active opportunities in the CRM, but stage movement appears to rely partly on internal salesperson judgement rather than agreed buyer actions, exit criteria or evidence of procurement progress. This may make the pipeline look healthier than it is.
Buying route and budget ownership are not yet controlled
The current pipeline relies on engaged champions, but budget source, approval sequence and procurement route are not consistently evidenced. This may create late-stage delay even where clinical or operational support is strong.
Pipeline confidence may be overstated
Several opportunities appear active because supplier follow-up is continuing, rather than because the buyer has agreed dated next actions. This weakens forecast confidence and may conceal stalled opportunities.
What happens next
A simple process designed to create useful commercial clarity quickly.
- 01Please confirm which review option you would like to proceed with.
- 02Lodestar Direction will then issue an invoice for the agreed amount.
- 03Once payment is received, you will receive the questionnaire link by email.
- 04Please complete the questionnaire, avoiding customer names, patient information or confidential commercial details.
- 05Lodestar Direction will review your responses and prepare your commercial review, which will be returned to you by email.
Next step
Ready to understand your NHS commercial readiness?
Request the review and receive a clear next step for your product, pipeline, procurement route and commercial priorities.